A once-monthly treatment for opioid use disorder

Mark Greenwald discusses buprenorphine extended release —a once-monthly injected formulation for the treatment of opioid use disorder recently approved by the US FDA.

Source: Listen to The Lancet - February 18, 2019 Category: General Medicine Authors: The Lancet Source Type: podcasts